Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition

Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition

Osteopontin (OPN) plays an important functional role in both physiologic and pathologic states. OPN is implicated in the progression of fibrosis, cancer, and metastatic disease in several organ systems. The epithelial-mesenchymal transition (EMT), first described in embryology, is increasingly being...

Full description

Bibliographic Details
Main Authors:	Anai N. Kothari, Matthew L. Arffa, Victor Chang, Robert H. Blackwell, Wing-Kin Syn, Jiwang Zhang, Zhiyong Mi, Paul C. Kuo
Format:	Article
Language:	English
Published:	MDPI AG 2016-03-01
Series:	Journal of Clinical Medicine
Subjects:	osteopontin epithelial-mesenchymal transition cancer-associated fibroblasts tumor microenvironment tumor metastasis fibrosis
Online Access:	http://www.mdpi.com/2077-0383/5/4/39

Similar Items

Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial–mesenchymal transition
by: Omer Faruk Hatipoglu, et al.
Published: (2021-07-01)

Interplay of Immunometabolism and Epithelial–Mesenchymal Transition in the Tumor Microenvironment
by: Ming-Yu Chou, et al.
Published: (2021-09-01)

Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients
by: Hongwang Song, et al.
Published: (2020-10-01)

Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition
by: Wenzhe Song, et al.
Published: (2017-09-01)

Epithelial-Mesenchymal Transition in tumor microenvironment
by: Jing Yingying, et al.
Published: (2011-08-01)

Master Regulators of Epithelial-Mesenchymal Transition and WNT Signaling Pathways in Juvenile Nasopharyngeal Angiofibromas
by: Naiade Calanca, et al.
Published: (2021-09-01)

Novel clinical therapeutics targeting the epithelial to mesenchymal transition
by: Anai N Kothari, et al.
Published: (2014-12-01)

The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition
by: Fernán Gómez-Valenzuela, et al.
Published: (2021-06-01)

Identification of Epithelial–Mesenchymal Transition-Related Prognostic lncRNAs Biomarkers Associated With Melanoma Microenvironment
by: Bo Xiao, et al.
Published: (2021-05-01)

How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
by: Alessandro Poggi, et al.
Published: (2018-02-01)

Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
by: Alessandro Poggi, et al.
Published: (2018-06-01)

Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice
by: Rikako Ishigamori, et al.
Published: (2017-05-01)

Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis
by: Jacek Baj, et al.
Published: (2020-04-01)

Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment
by: Edoardo D'Angelo, et al.
Published: (2020-07-01)

Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology
by: Olena Bilyk, et al.
Published: (2017-07-01)

Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels
by: Jing Huang, et al.
Published: (2021-06-01)

Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial–Mesenchymal Transition Score in Prognosis Prediction
by: Ying-Chieh Ko, et al.
Published: (2020-06-01)

Epithelial-mesenchymal Transition and Tumor Metastasis
by: Rongzhi ZHAO, et al.
Published: (2011-07-01)

Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial–Mesenchymal Transition Activity States
by: Ji-Yong Sung, et al.
Published: (2021-04-01)

LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition
by: Jing Li, et al.
Published: (2019-02-01)

Epithelial-mesenchymal Transition and Tumor Drug Resistance
by: Linlin ZHANG, et al.
Published: (2013-01-01)

In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets
by: Sebastian G. Walter, et al.
Published: (2021-03-01)

Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis
by: Guya D. Marconi, et al.
Published: (2021-06-01)

Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
by: Isabel J. Dionísio de Sousa, et al.
Published: (2020-07-01)

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
by: Yuliya Klymenko, et al.
Published: (2017-08-01)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
by: Si-yuan Zhang, et al.
Published: (2021-07-01)

The Role of Cancer-Associated Fibroblasts in Tumor Progression
by: Rushikesh S. Joshi, et al.
Published: (2021-03-01)

Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
by: Simone Brivio, et al.
Published: (2015-12-01)

Do Anti-Osteopontin Auto-Antibodies Arise in Cancer Patients?
by: Alsarkhi, Lamyaa
Published: (2017)

PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers
by: Tiantian Wu, et al.
Published: (2021-09-01)

Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma
by: Long Yan, et al.
Published: (2018-08-01)

The interplay of autophagy and epithelial-to-mesenchymal transition in cancer progression
by: O. O. Ryabaya, et al.
Published: (2020-09-01)

Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors
by: Ali Nazarizadeh, et al.
Published: (2021-08-01)

Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway
by: Yen-Hsiu Yeh, et al.
Published: (2018-03-01)

Prognostic and predictive significance of osteopontin in malignant neoplasms
by: E. Yu. Zubareva, et al.
Published: (2021-07-01)

Potential Therapeutic Role of Osteopontin Inhibition in Liver Fibrosis -Induced by Thioacetamide in Rats
by: Ramadan A., et al.
Published: (2017-10-01)

Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review
by: Barbora Peltanova, et al.
Published: (2019-03-01)

Osteopontin Plays a Critical Role in Interstitial Fibrosis but Not Glomerular Sclerosis in Diabetic Nephropathy
by: Tomoaki Nagao, et al.
Published: (2012-03-01)

Investigating epithelial‐mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling
by: Federico Bocci, et al.
Published: (2021-06-01)

Tacrolimus Modulates TGF-β Signaling to Induce Epithelial-Mesenchymal Transition in Human Renal Proximal Tubule Epithelial Cells
by: Jason Bennett, et al.
Published: (2016-04-01)